Med-Chemist : "Quintessential Medicinal Chemistry"
Friday, June 19, 2015
Common bacteria on verge of becoming antibiotic-resistant superbugs
›
Anti biotic resistance is poised to spread globally among bacteria frequently implicated in respiratory and urinary infections in hosp...
Thursday, June 18, 2015
New drug fails to prevent irreversible injury to the heart after angioplasty
›
Patients who received the new drug Bendavia before undergoing angioplasty or receiving a stent to clear blocked arteries after a hea...
Sildenafil drug may effectively relieve nerve damage in men with long-term diabetes
›
New animal studies at Henry Ford Hospital found that sildenafil, a drug commonly used to treat erectile dysfunction, may be effective in r...
Wednesday, June 17, 2015
FDA approves CHOLBAM (cholic acid) for treatment of bile acid synthesis disorders
›
Asklepion Pharmaceuticals, LLC. today announced that the U.S. Food and Drug Administration (FDA) approved CHOLBAM™ (cholic a...
Tuesday, June 16, 2015
CASI initiates ENMD-2076 Phase 2 trial in Chinese patients with triple-negative breast cancer
›
CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical company dedicated to the acquisition, development and commer...
Monday, June 15, 2015
Existing drugs could help prevent deadly familial stomach and lobular breast cancers
›
Deadly familial stomach and lobular breast cancers could be successfully treated at their earliest stages, or even prevented, by existing ...
Friday, June 12, 2015
Saccharin could potentially lead to development of drugs for difficult-to-treat cancers
›
Saccharin, the artificial sweetener that is the main ingredient in Sweet 'N Low®, Sweet Twin® and Necta®, could do far more than...
Thursday, June 11, 2015
Isis Pharmaceuticals announces positive results from ISIS-ANGPTL3Rx Phase 1 study
›
Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today positive results from a Phase 1 study with ISIS-ANGPTL3 Rx . In this study, heal...
Wednesday, June 10, 2015
Glyxambi for Type 2 diabetes treatment now available by prescription across the U.S.
›
In continuation of my update on empagliflozin / linagliptin Glyxambi® (empagliflozin/linagliptin) ta...
Tuesday, June 9, 2015
Study explains why COPD patients develop tolerance to roflumilast drug
›
Roflumilast, a drug recently approved in the United States to treat severe chronic obstructive pulmonary disease (COPD), increases th...
Monday, June 8, 2015
Fourth-line bosutinib ‘appropriate’ after prior CML treatment failure, intolerance
›
In continuation of my update on bosutinib A Spanish study suggests that bosutinib can help improve or maintain response in pati...
Friday, June 5, 2015
BCM-95 Curcumin improves chemotherapy's effectiveness in killing chemoresistant cancer cells
›
The structure of curcumin , officially known as diferuloylmethane, is two ferulic acid moeities bound together with an additional carbon...
Thursday, June 4, 2015
Two common antibiotic treatments equally effective against MRSA skin infections
›
Researchers funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have f...
Tuesday, June 2, 2015
RNA molecule can be manipulated to generate more neurons from neural stem cells
›
A research team at UC San Francisco has discovered an RNA molecule called Pnky that can be manipulated to increase the production of neuro...
Monday, June 1, 2015
New triple combination therapy shows promise in controlling advanced melanoma
›
Results of a new study by UCLA researchers has found that a groundbreaking new triple combination therapy shows promising signs of more ef...
‹
›
Home
View web version